HEALTHCARE
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%
Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with...
HEALTHCARE
Pharmaceutical stocks rise as Trump pauses tariffs but not for China
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023.Mike Blake | ReutersShares of some drugmakers rose on Wednesday after President...
HEALTHCARE
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump's goal of bringing manufacturing back to the United...
HEALTHCARE
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Signage at the AstraZeneca facility in Gaithersburg, Maryland, US, on Monday, Aug. 26, 2024. Graeme Sloan | Bloomberg | Getty ImagesA version of this...
HEALTHCARE
Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty...
HEALTHCARE
AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe
AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British...
Subscribe
– Stay updated in real-time
– Get in-depth insights and trends
– News straight to your inbox
Must read